Kåre Schultz

Revenue plunges, stock takes a drubbing, but Teva CEO Kåre Schultz still grabs $32.5M in chart-topping compensation
Revenue plunges, stock takes a drubbing, but Teva CEO Kåre Schultz still grabs $32.5M in chart-topping compensation
Endpoints
Teva Pharmaceutical
Kåre Schultz
Pharma CEOs
executive pay
Flag link:
Kare Schultz, Teva CEO, announces new data showing the worst phase is now over
Kare Schultz, Teva CEO, announces new data showing the worst phase is now over
GoinPharma
Teva Pharmaceutical
debt
JPMHC 2019
Kåre Schultz
Pharma CEOs
Flag link:
Teva implements impressive recovery strategy
Teva implements impressive recovery strategy
GoinPharma
Teva Pharmaceutical
Kåre Schultz
restructuring
Flag link:
Teva joins the executive pay big leagues after doling out $17M to new CEO Kare Schultz
Teva joins the executive pay big leagues after doling out $17M to new CEO Kare Schultz
Fierce Pharma
Teva Pharmaceutical
executive pay
Kåre Schultz
Pharma CEOs
Flag link:
Teva chief reports 'strong progress' in restructuring plan
Teva chief reports 'strong progress' in restructuring plan
CNBC
Teva Pharmaceutical
restructuring
layoffs
Kåre Schultz
Pharma CEOs
Flag link:
Time for weighing things up for Kare Schultz, Teva CEO: group gains $8bn in capitalization in two months
Time for weighing things up for Kare Schultz, Teva CEO: group gains $8bn in capitalization in two months
GoinPharma
Teva Pharmaceutical
Pharma CEOs
Kåre Schultz
Flag link:
Teva's new launches won't feel the sting of hefty cost cuts: CEO
Teva's new launches won't feel the sting of hefty cost cuts: CEO
Fierce Pharma
Teva Pharmaceutical
drug launches
Pharma CEOs
Kåre Schultz
layoffs
Austedo
fremanezumab
Flag link:
Roiled by financial turmoil, Teva’s CEO boots R&D chief, top execs in C-suite overhaul
Roiled by financial turmoil, Teva’s CEO boots R&D chief, top execs in C-suite overhaul
Endpoints
Teva Pharmaceutical
Pharma CEOs
Kåre Schultz
R&D
executives
Flag link:
Teva R&D chief out as new CEO picks up the ax and aims at deep cuts to rescue a faltering biopharma — report
Teva R&D chief out as new CEO picks up the ax and aims at deep cuts to rescue a faltering biopharma — report
Endpoints
Teva Pharmaceutical
R&D
layoffs
Kåre Schultz
Flag link:
Hard times for Teva Pharmaceutical
Hard times for Teva Pharmaceutical
GoinPharma
Teva Pharmaceutical
Copaxone
Kåre Schultz
Flag link:
New pharma CEOs to face payer, pricing challenges
New pharma CEOs to face payer, pricing challenges
Medical Marketing and Media
Pharma CEOs
Novartis
Teva Pharmaceutical
Kåre Schultz
Vasant Narasimham
payers
drug pricing
Flag link:
Teva CEO gets lots of advice on how to fix beleaguered company, even before he begins
Teva CEO gets lots of advice on how to fix beleaguered company, even before he begins
Fierce Pharma
Teva Pharmaceutical
Pharma CEOs
Kåre Schultz
Flag link:
Teva lures Lundbeck chief Schultz with $52M package that makes him among pharma's top paid
Teva lures Lundbeck chief Schultz with $52M package that makes him among pharma's top paid
Fierce Pharma
Teva Pharmaceutical
executive pay
Pharma CEOs
Lundbeck
Kåre Schultz
Flag link:
Troubled Teva poaches Lundbeck CEO Schultz with an offer he couldn’t refuse, including $20M in cash
Troubled Teva poaches Lundbeck CEO Schultz with an offer he couldn’t refuse, including $20M in cash
Endpoints
Teva Pharmaceutical
Lundbeck
Pharma CEOs
Kåre Schultz
Flag link:
Former Novo exec Schultz will become a CEO after all—just at another pharma
Former Novo exec Schultz will become a CEO after all—just at another pharma
BioPharma Dive
Novo Nordisk
Pharma CEOs
Lundbeck
Kåre Schultz
Flag link:
Novo's purported CEO-to-be is out the door amid executive reshuffle
Novo's purported CEO-to-be is out the door amid executive reshuffle
Fierce Pharma
Novo Nordisk
Pharma CEOs
Kåre Schultz
Flag link: